Clinical Trials Browser

Phase 2/3 × OTHER × Osteosarcoma × Clear all

NCT05057130 2024-04-01

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

Phase 2/3 Recruiting

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

NCT02856048 2019-12-17

PRESOV

Phase 2/3 Unknown

LymphoidSarcoma

Lymphoma, Neoplasms, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT02711007 2018-04-23

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Phase 2/3 Completed

Neoplasm Metastasis, Osteosarcoma